Efficacy of trabectedin in metastatic solitary fibrous tumor

Rare Tumors

Volumn 3, Issue 3, 2011, Pages 92-94

  Chaigneau, Loïc ^a   Kalbacher, Elsa ^a   Thiery Vuillemin, Antoine ^a   Fagnoni Legat, Christine ^a   Isambert, Nicolas ^b   Aherfi, Lionel ^a   Pauchot, Julien ^a   Delroeux, Delphine ^a   Servagi Vernat, Stephanie ^c   Mansi, Laura ^a   Pivot, Xavier ^a  

^a Universitary Hospital Center J Minjoz   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Metastatic solitary fibrous tumor; Trabectedin

Indexed keywords

DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; IFOSFAMIDE; MESNA; TRABECTEDIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG BIOPSY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PHYSICAL EXAMINATION; PROGNOSIS; SEPTIC SHOCK; SOLITARY FIBROUS TUMOR; THORAX RADIOGRAPHY;

EID: 79960983277     PISSN: 20363605     EISSN: 20363613     Source Type: Journal    
DOI: 10.4081/rt.2011.e29     Document Type: Article

References (14)

1. FNCLCC and the French sarcoma group. Consolidation with high dose chemotherapy for responding patients to standard chemotherapy in advanced, metastatic. Not published results.
2. http://www.medicines.org.uk/EMC/medi-cine/20457/SPC/Yondelis+0.25+mg
3. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989; 13: 640-58.
4. Guillou L, Gebhard S, Coindre JM. Orbital and extraorbital giant cell angiofibroma: a giant cell-rich variant of solitary fibrous tumor? Clinicopathologic and immunhis-tochemical analysis of a series of a unifying concept. Am J Surg Pathol 2000; 24: 971-9.
5. Goodlad JR, Fletcher CDM. Solitary fibrous tumour arising at unusual sites: analysis of a series. Histopathology 1991; 19: 515-22.
6. Suster S, Nascimento AG, Miettinen M, et al. Solitary fibrous tumors of soft tissue. A clinicopathologic and immunohistochemi-cal study of 12 cases. Am J Surg Pathol 1995; 19: 1257-66.
7. Brunnemann R, Ro JY, Ordonez NG, et al. Extrathoracic solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol 1999; 12: 1034-42.
8. Hasegawa T, Matsuno Y, Shimoda T, et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behaviour. Hum Pathol 1999; 30: 1464-73.
9. Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohisto-chemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995; 26: 440-9.
10. Guillou L, Gebhard S, Coindre JM. Lipomatous hemangiopericytoma: a fat-containing variant of solitary fibrous tumor? Clinicopathologic, immunohisto-chemical, and ultrastructural analysis of a series in favor of a unifying concept. Hum Pathol 2000; 31: 1108-15.
11. Scotto KW. ET-743: more than an innovative mechanism of action. Anticancer drugs 2002; 13: S3-6.
12. Fayette J, Ray-Coquard I, Alberti L, et al. ET-743: a novel agent with activity in soft tissue sarcomas. The Oncologist 2005; 10: 827-32.
13. Demitri G D, Chawla SP, Von Mehren M, et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcome after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 2009; 27: 4188-96.
14. Monk BJ, Herzog TJ, Kaye SB, et al. Trabectedin plus pegylated liposomal dox-orubicin in recurrent ovarian cancer. J Clin Oncol 2010; 28: 3107-14.